Close Menu

nasopharyngeal cancer

Researchers are making improvements to viral-DNA detection methods and are exploring applications not just for screening but also disease monitoring.

Take2 Health plans to launch an nasopharyngeal carcinoma early detection test in the next several months in Hong Kong and southern China.

Take2 was founded by Chinese University of Hong Kong researchers and will commercialize a cell-free DNA test for early cancer detection.